Botulinum toxin type A for the treatment of postamputation residual limb myokymia: a case report

PM R. 2010 Aug;2(8):777-9. doi: 10.1016/j.pmrj.2010.03.036.

Authors

Shashank J Dave¹, Joshua Salyer, Kevin A Desai

Affiliation

¹ Department of Physical Medicine and Rehabilitation, and Neurology, Indiana University School of Medicine, Indianapolis, IN, USA.

PMID: 20709306
DOI: 10.1016/j.pmrj.2010.03.036

No abstract available

Publication types

Case Reports

MeSH terms

Amputation, Surgical / adverse effects*
Botulinum Toxins, Type A / therapeutic use*
Female
Humans
Lower Extremity*
Middle Aged
Myokymia / diagnosis
Myokymia / drug therapy*
Myokymia / etiology*
Neuromuscular Agents / therapeutic use*

Substances

Neuromuscular Agents
Botulinum Toxins, Type A